Danya Institute Inc.

Best Practices

Adapting EBPs for Under-resourced Populations

From SAMHSA SAMHSA released the guide Adapting Evidence-based Practices for Under-resourced Populations in September 2022. This guide focuses on research supporting adaptations of evidence-based practices (EBPs) for under-resourced populations. Adaptations involve tailoring care, programs, and services to the cultural, social, gender, and demographic contexts of the people served to yield positive outcomes.


FDA Overdose Prevention Framework

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services’ Overdose Prevention Strategy to address the public health emergency as it continues to evolve. The overdose crisis is an evolving public health crisis; as such, FDA continues to evaluate our approach and make adjustments according to the latest […]


Burnout in the BH Workforce

From SAMHSA Addressing Burnout in the Behavioral Health Workforce through Organizational Strategies September 2022 Burnout is a complex issue resulting from chronic workplace stress that encompasses exhaustion, depersonalization, and reduced personal accomplishment. This guide will highlight organization-level interventions to prevent and reduce burnout among behavioral health workers.


Improving Tobacco-Related Health Disparities

A CDC feature article Health equity is the fair and just opportunity for all people to be as healthy as possible, and that includes the opportunity to be free from commercial* tobacco. Yet, some people don’t have this opportunity because of factors like their race or ethnicity, where they live, or what kind of job they […]


Realistic Treatment

From Health Affairs, Nora D. Volkow Making Addiction Treatment More Realistic And Pragmatic: The Perfect Should Not Be The Enemy Of The Good Last year saw drug overdose deaths in the U.S. surpass an unthinkable milestone: 100,000 deaths in a year. This is the highest number of drug overdoses in our country’s history, and the […]


Toolkit: Telehealth & OUD

The Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care, released in October 2021, focuses on buprenorphine (typically formulated as buprenorphine/naloxone, hereafter termed buprenorphine) and adjunctive psychotherapy treatment options for OUD and does not cover methadone treatment or XR-naltrexone. The primary goal of this toolkit is to provide clinically relevant information to support […]


COVID-19 Vaccinations

BLOG June 11, 2021 By Dr. Nora Volkow Substance use disorders (SUDs) are among several health conditions that have been identified by the CDC as increasing a person’s risk for becoming severely ill from COVID-19. For this reason, it is especially important that people who use or are addicted to drugs become vaccinated. Because people […]


AAAP awarded 2-yr, $32M opioid grant

The American Academy of Addiction Psychiatry (AAAP) has been awarded a 2-year grant of $32 million from the Substance Abuse and Mental Health Services Administration (SAMHSA) to address opioid use disorders and stimulant use disorders. The Addiction Technology Transfer Center (ATTC) network is part of the grant’s coalition of 40 national professional organizations. The Opioid […]